Dermal fibroblasts and extracellular matrix components

Dermal fibroblasts are the principal mesenchymal cells of the skin dermis, primarily responsible for the production, maintenance, and remodeling of the extracellular matrix (ECM) [StatPearls: Physiology, Connective Tissue]. The ECM itself is a complex scaffold composed of fibrous proteins like collagen and elastin, as well as glycosaminoglycans and proteoglycans, which provide structural support and regulate cell behavior [NCBI: The Extracellular Matrix of the Skin]. In normal physiology, these components are essential for wound healing and skin elasticity; however, their dysregulation is central to various pathologies [PubMed: Fibroblasts in fibrosis and resolution]. For instance, excessive fibroblast activation and ECM deposition lead to fibrotic conditions such as keloids and systemic sclerosis, while their degradation and diminished synthesis characterize skin aging and chronic wounds [Journal of Investigative Dermatology: Skin Aging]. Pharmacological intervention often involves modulating fibroblast activity through signaling pathways like TGF-beta or using agents like retinoids to stimulate collagen production [PubChem: Tretinoin]. Additionally, direct modification of the ECM is achieved through injectable fillers like hyaluronic acid or enzymatic treatments like collagenase to break down pathological fibrous tissue [FDA: Xiaflex].

Other names

Skin fibroblastsDermal ECMConnective tissue matrixDermal interstitial matrix

Modulation of fibroblast proliferation, stimulation of collagen synthesis, or enzymatic degradation of extracellular matrix proteins.